Receptos, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
Don’t Get Caught When This Bubble Bursts
Article By: Bret Jensen
Tuesday, July 21, 2015 10:18 PM EST
The enthusiasm for the small cap biotech sector is quite something right now. This is understandable given the top gainers within the market during the first half of 2015 is dominated by names from this space but this sort of rally cannot continue.
In this article: CELG, EGRX, GILD, HALO, JUNO, RCPT, SGYP, ZIOP
Read
Biotech Mania: Another Deal, Another Rally To New Highs
Article By: Rod Raynovich
Thursday, July 16, 2015 11:20 PM EST
The market mentality now is that by the end of the year more multi-$B deals will be struck so companies with later stage biotech pipelines will outperform the market. For now don’t fight momentum don’t fight the FED.
In this article: ABBV, CELG, GILD, IBB, PCYC, RCPT, REGN, XBI, XLV
Read
Analysts Provide Insight On Celgene Corporation And Receptos, Inc. In Light Of Acquisition Announcement
Article By: TipRanks
Thursday, July 16, 2015 11:08 AM EST
Celgene will pay $7.2 billion in cash for the autoimmune drug maker. The boards of both companies have approved the terms of the acquisition and expect it to close before the end of the quarter.
In this article: CELG, RCPT
Read
Receptos - Chart Of The Day
Article By: Jim Van Meerten
Wednesday, July 15, 2015 8:44 PM EST
Since the Trend Spotter signaled a buy on 5/12 the stock gained 37.49%.
In this article: RCPT
Read
E Celgene To Buy Receptos For $7.3B In All Cash Acquisition
Article By: Terry Chrisomalis
Tuesday, July 14, 2015 6:26 PM EST
Celgene is paying $232 per share or $7.3B in cash to acquire Receptos. CELG up almost 6%AH.
In this article: CELG, RCPT
Read

PARTNER HEADLINES

Latest Tweets for $RCPT

No tweets yet!